Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents.
D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy; D002707:Chlordiazepoxide; D003913:Dextroamphetamine; D004195:Disease Models, Animal; D004338:Drug Combinations; D005106:Exploratory Behavior / Q000187:drug effects; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced / Q000188:drug therapy*; D007274:Injections, Intraperitoneal; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use*; D008781:Methyltyrosines / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D011292:Premedication; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D004338:Drug Combinations; D008781:Methyltyrosines; D002707:Chlordiazepoxide; D008094:Lithium; D014446:Tyrosine 3-Monooxygenase; D003913:Dextroamphetamine